The Trump administration has proposed a rule requiring employer-sponsored health plans to expand coverage of fertility benefits, drawing mixed reactions from healthcare industry leaders.
The proposed rule addresses reproductive health services under the Employee Retirement Income Security Act (ERISA) and the Internal Revenue Code. It mandates that employers offering health insurance must include coverage for fertility treatments, including in vitro fertilization (IVF), egg freezing, and related diagnostic services.
Healthcare executives split over implementation costs and scope. Some industry leaders support the expansion, arguing that fertility coverage addresses workforce retention and gender equity in benefits packages. Others warn the mandate imposes substantial compliance burdens and premium increases on employers, particularly small and mid-size firms.
Insurance carriers face questions about plan design and coverage parameters. The rule requires determination of what constitutes "fertility services" and establishes standards for medical necessity determinations. Some health plans already voluntarily cover fertility treatments; the regulation standardizes these benefits across the industry.
Legal experts note the rule operates within ERISA's framework governing employer-sponsored health plans. The proposal triggers a notice-and-comment period before finalization, allowing stakeholders to submit formal objections or support.
Reproductive health advocates view the rule as progress toward comprehensive fertility care access. Business groups caution that expanded mandates without adequate transition periods strain budgets and increase administrative complexity.
The regulation applies to group health plans covering 50 or more employees. Self-insured employers and small businesses face different compliance timelines. States may implement stronger fertility benefit requirements under their own insurance codes, creating a patchwork of overlapping obligations.
Healthcare leaders must assess actuarial impacts and network adequacy for fertility services. The rule requires plan sponsors to establish coverage determinations, appeals processes, and provider networks within specified timeframes. Legal and benefits counsel should prepare for implementation guidance expected in regulatory notices before the rule's effective date.
The proposal reflects ongoing debate over federal